Clinical Trials for Acute Lymphoblastic Leukemia ALL

Find clinical trials for acute lymphoblastic leukemia all. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

NCT ID: NCT06882057

This clinical trial, called CCCG-ALL2025 LR-B-ALL, is designed to help children who have recently been diagnosed with a specific type of leukemia called low-risk B-cell acute lymphoblastic leukemia...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China, Guangzhou, Guangdong, China +24 more

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

NCT ID: NCT06845592

This clinical trial is investigating a new treatment approach for patients with high-risk acute leukemia, specifically those with Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)....

Recruiting

Phase: NA Type: interventional Locations: Perugia, Pg, Italy

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

NCT ID: NCT06764238

The CCCG-ALL-2025 clinical trial is focused on improving treatment for children diagnosed with intermediate or high-risk B-cell acute lymphoblastic leukemia (B-ALL), a type of cancer that affects t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China, Jinan, Shandong, China +24 more

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

NCT ID: NCT06721598

This clinical trial is looking at a treatment called anti-CD19 CAR-T cell therapy for adults with certain types of blood cancers, specifically Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia ...

Not yet recruiting

Type: observational Locations: Moscow, , Russian Federation

A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

NCT ID: NCT06705530

This clinical trial is testing a new treatment called anti-CD19 CAR-T cell therapy for adults with certain blood cancers, specifically Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia (ALL), t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Moscow, , Russian Federation

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

NCT ID: NCT06608342

This clinical trial is studying a new treatment approach for adults with high-risk acute lymphoblastic leukemia (ALL), a type of blood cancer. The treatment combines two methods: a procedure called...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions